Top Section/Ad
Top Section/Ad
Most recent
DocMorris announces Sfr200m rights issue expected in May
Stock drops 17% in highly volatile market
Deal follows steep share price fall
More articles/Ad
More articles/Ad
More articles
-
Shanghai Pharmaceuticals Holding Co has managed to slice the margin and fees on a $500m comeback to the loan market. -
LinkDoc Technology, a cancer-focused medical data company, has shelved its US IPO just hours before pricing, as Chinese technology stocks recoil from Beijing’s clampdown on overseas listings.
-
EMC, the Russian private healthcare company, has unveiled the price range for its IPO on the Moscow Exchange.
-
Consultancy firm Oliver Wyman said in a report this week that European banks will face a delayed credit impact from the coronavirus pandemic if they fail to unwind emergency government support measures properly.
-
Chinese biotechnology company Brii Biosciences has raised HK$2.48bn ($319.7m) from its Hong Kong IPO, after pricing the deal at the top of the marketed range.
-
South Korea’s busy IPO market is continuing to pump out deals, with the latest listings coming from Kakao Pay and Covid-19 test maker SD Biosensor. But issuers still have to be realistic, as Krafton found out when it shot for, but missed, the country’s largest ever IPO.
